Jinhai Medical Technology (02225) released annual results and achieved revenue of SGD 50,241,000, an increase of 10.07% year-on-year

According to the Zhitong Finance App, Jinhai Medical Technology (02225) announced the results for the year ended December 31, 2024. The group achieved revenue of SGD 50,241,000 during the period, an increase of 10.07% over the previous year.

According to the announcement, the increase in revenue was mainly due to the growth of the minimally invasive surgery solutions business in China in recent years, which led to an increase in the group's revenue during the year.

Revenue from minimally invasive surgical solutions and medical products and related service fees increased from SGD 20.4 million in FY2023 to SGD 25.9 million in FY2024. The increase was mainly due to growth in the minimally invasive surgical solutions business in China.

In view of the positive market feedback on minimally invasive surgical solutions, medical products and related services, the Group's revenue has increased dramatically, and the Group will continue to strengthen its position in the medical industry by (a) strengthening its development capabilities; (b) expanding its distribution network; (c) developing new products; and (d) promoting resource integration, developing and enhancing its competitiveness in the increasingly fierce market competition.